DIAGNOSEX Trademark

Trademark Overview

On Thursday, February 22, 2024, a trademark application was filed for DIAGNOSEX with the United States Patent and Trademark Office. The USPTO has given the DIAGNOSEX trademark a serial number of 98417208. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Thursday, September 12, 2024. This trademark is owned by DIAGNOSEX,INC.. The DIAGNOSEX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of mRNA drugs; Research and development of siRNA drugs
diagnosex

General Information

Serial Number98417208
Word MarkDIAGNOSEX
Filing DateThursday, February 22, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateThursday, September 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Description of MarkThe mark consists of DIAGNOSEX means try all the best to find or explore new testing and medications for humans diseases all over the world!.
Indication of Colors claimedThe color(s) Yellow pink blue is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of mRNA drugs; Research and development of siRNA drugs

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, February 22, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDIAGNOSEX,INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Thursday, February 22, 2024NEW APPLICATION ENTERED
Saturday, June 29, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 12, 2024NON-FINAL ACTION E-MAILED
Thursday, September 12, 2024NON-FINAL ACTION WRITTEN
Thursday, September 12, 2024NON-FINAL ACTION E-MAILED
Thursday, September 12, 2024NON-FINAL ACTION E-MAILED
Thursday, September 12, 2024NON-FINAL ACTION WRITTEN
Thursday, September 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 12, 2024NON-FINAL ACTION WRITTEN
Thursday, September 12, 2024ASSIGNED TO EXAMINER
Thursday, September 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, September 12, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

diagnosex drugs research development sirna mrna